EG 427
Paris
About EG 427
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $48.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2025)
- Website: eg427.com
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eg-427-81084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.